TAS-108, a Novel Oral Steroidal Antiestrogenic Agent, Is a Pure Antagonist on Estrogen Receptor α and a Partial Agonist on Estrogen Receptor β with Low Uterotrophic Effect

Yasuji Yamamoto, Tadafumi Terada|Clinical Cancer Research|2005

Cited by 31